Skip to content

"A Trial to Determine the Efficacy of Amizate in Mild to Severe Malnutrition Children of India"

Seeding Program/User trial of Amizate (Used as Nutritional Suplement) in mild & severe malnutrition children (as per Gomezs classification) in india. - -

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/09/002000
Enrollment
438
Registered
2011-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Children with mild, moderate or severe malnutrition as per Gomezs Classification.

Interventions

Intervention1: Amizate 3 grams: Amizate 3 grams with chocolate drinks, once a day, for 120days(4 months). Intervention2: Amizate 6 grams: Amizate 6 grams with chocolate drinks, once a day, for 120days

Sponsors

Zymtech Production AS
Lead Sponsor
Consortium Clinical Research Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and Female children, aged between 6 and 8 years. 2. Generally healthy (not having any serious diseases or indications or infections, which will be needing medical attention in a normal circumstance) on clinical examination as per the discretion of the physician on screening. 3. Ability and willingness of parent or legally acceptable representative to give written informed consent. 4. Ability and willingness of children to give assent. 5. Children with mild, moderate or severe malnutrition as per Gomez?s Classification. 6. The child must not be on any other nutritional supplement that is marketed, (if so, must be willing to withdraw consumption of the same immediately ? until this Seeding Program / User Trial is completed).

Exclusion criteria

Exclusion criteria: 1. History of cardiovascular or respiratory or any other diseases on clinical examination. 2. Physical disability, which limits performance of tests. 3. Indication that they are likely to move outside the Seeding Program / User Trial facility?s locality within the period Seeding Program / User Trial intervention.

Design outcomes

Primary

MeasureTime frame
Change in the weight, weight for age, height for age, weight for height, height Improvement in physical performance Improvement in cognitive performance Change in Minerals level, blood parameters, Lipid Profile, Liver Function Tests, Renal Function Tests, Assay for Immunological Parameters, urinalysis parameters Treatment-emergent serious adverse events Treatment discontinuation due to adverse events Timepoint: From Baseline till the End of Trial

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactMrs Nagalakshmi AnandaPadmanabhan

-

naga@consortiumcr.com04222622225

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026